Trial intelligence / Profile preview

Hypertonic saline hydroxyethyl starch 40 vs mannitol in elderly intracranial tumour neurosurgery

ChiCTR-IPR-16009005Phase 4Recruiting

Sponsor
Renmin Hospital of Wuhan University
Start
Aug 2016
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 4 trial of Bronchitol and HyperHAES in Intracranial Tumors (3 arms), sponsored by Renmin Hospital of Wuhan University. Primary endpoints: Blood pressure, Heart rate and 6 more. Started Aug 2016; status: recruiting.

02

Drugs

BronchitolHyperHAES
03

Conditions

Intracranial Tumors

Beyond the preview

Go deeper on ChiCTR-IPR-16009005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-16009005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call